ArticleFrontiers in bioengineering and biotechnology2022
SL-HarDNet: Skin lesion segmentation with HarDNet.
Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Advancements and challenges of artificial intelligence in dermatology: a review of applications and perspectives in China.Frontiers in digital health · 2025Pooled it
- WA-NET: enhanced boundary-aware segmentation of skin lesions via frequency-spatial feature fusion and attention-guided edge refinement.Scientific reports · 2025Article
- Automated MRI system for clinically significant prostate cancer detection development validation and real-world implementation.Nature communications · 2025Article
- Two-dimensional segmentation fusion tool: an extensible, free-to-use, user-friendly tool for combining different bidimensional segmentations.Frontiers in bioengineering and biotechnology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Automatic segmentation of skin lesions from dermoscopy is of great significance for the early diagnosis of skin cancer. However, due to the complexity and fuzzy boundary of skin lesions, automatic segmentation of skin lesions is a challenging task. In this paper, we present a novel skin lesion segmentation network based on HarDNet (SL-HarDNet). We adopt HarDNet as the backbone, which can learn more robust feature representation. Furthermore, we introduce three powerful modules, including: cascaded fusion module (CFM), spatial channel attention module (SCAM) and feature aggregation module (FAM). Among them, CFM combines the features of different levels and effectively aggregates the semantic and location information of skin lesions. SCAM realizes the capture of key spatial information. The cross-level features are effectively fused through FAM, and the obtained high-level semantic position information features are reintegrated with the features from CFM to improve the segmentation performance of the model. We apply the challenge dataset ISIC-2016&PH2 and ISIC-2018, and extensively evaluate and compare the state-of-the-art skin lesion segmentation methods. Experiments show that our SL-HarDNet performance is always superior to other segmentation methods and achieves the latest performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.